Skip to main content
. 2017 Feb 28;8(12):19843–19854. doi: 10.18632/oncotarget.15773

Figure 6:

Figure 6:

In vitro clonogenic assay. Data are represented as number of colonies in BCPAP cells and K1 cells treated with DMSO, 0.1 μM dabrafenib/2.5 μM selumetinib alone or in combination with 1 μM lapatinib with (131I+) or without 131I (131I-). Data are expressed as mean ± SD. Da: dabrafenib; Se: selumetinib; La: lapatinib.